Literature DB >> 12848999

Primary biliary cirrhosis and hepatocellular carcinoma.

Jorge Findor1, Xiao-Song He, Juan Sord, Ruben Terg, M Eric Gershwin.   

Abstract

The findings by epidemiological studies on the link between PBC and HCC are in general agreement with the notion that cirrhosis is a risk factor for HCC development. From the clinical perspective, this implies that in PBC patients with cirrhosis, the screening for HCC should be considered for evaluating prognosis as well as therapeutic options. At this time, it is not possible to determine whether any PBC-specific risk factors other than cirrhosis per se exist for the development of HCC. Identification of such risk factors may point to new mechanisms involved in the carcinogenesis of HCC. In order to answer the question whether the underlying mechanisms for PBC are risk factors for HCC, more aggressive clinical studies with larger patient populations are needed. Such studies should include patients with PBC as well as patients with cirrhosis of other etiologies, both have to be carefully matched for patient characteristics including race, gender, age, disease stage and period of follow-up. On the other hand, the resolution of this issue also relies on a better understanding of the molecular pathogenesis of PBC itself.

Entities:  

Mesh:

Year:  2002        PMID: 12848999     DOI: 10.1016/s1568-9972(02)00050-2

Source DB:  PubMed          Journal:  Autoimmun Rev        ISSN: 1568-9972            Impact factor:   9.754


  10 in total

1.  Primary biliary cirrhosis-associated hepatocellular carcinoma in Chinese patients: incidence and risk factors.

Authors:  Xue-Xiu Zhang; Li-Feng Wang; Lei Jin; Yuan-Yuan Li; Shu-Li Hao; Yan-Chao Shi; Qing-Lei Zeng; Zhi-Wei Li; Zheng Zhang; George Kk Lau; Fu-Sheng Wang
Journal:  World J Gastroenterol       Date:  2015-03-28       Impact factor: 5.742

2.  Sustained phosphorylation of Bid is a marker for resistance to Fas-induced apoptosis during chronic liver diseases.

Authors:  Arndt Vogel; Joseph E Aslan; Holger Willenbring; Christian Klein; Milton Finegold; Howard Mount; Gary Thomas; Markus Grompe
Journal:  Gastroenterology       Date:  2006-01       Impact factor: 22.682

Review 3.  Primary biliary cholangitis: a comprehensive overview.

Authors:  Ana Lleo; Simona Marzorati; Juan-Manuel Anaya; M Eric Gershwin
Journal:  Hepatol Int       Date:  2017-11-21       Impact factor: 6.047

4.  Id2 leaves the chromatin of the E2F4-p130-controlled c-myc promoter during hepatocyte priming for liver regeneration.

Authors:  José L Rodríguez; Juan Sandoval; Gaetano Serviddio; Juan Sastre; María Morante; Maria-Giulia Perrelli; María L Martínez-Chantar; José Viña; Juan R Viña; José M Mato; Matías A Avila; Luis Franco; Gerardo López-Rodas; Luis Torres
Journal:  Biochem J       Date:  2006-09-15       Impact factor: 3.857

5.  Familiarity Breeds Strategy: In Silico Untangling of the Molecular Complexity on Course of Autoimmune Liver Disease-to-Hepatocellular Carcinoma Transition Predicts Novel Transcriptional Signatures.

Authors:  Soumyadeep Mukherjee; Arpita Kar; Najma Khatun; Puja Datta; Avik Biswas; Subhasis Barik
Journal:  Cells       Date:  2021-07-29       Impact factor: 6.600

Review 6.  Incidence and risk factors for hepatocellular carcinoma in primary biliary cirrhosis.

Authors:  Guanghua Rong; Hong Wang; Christopher L Bowlus; Chunping Wang; Yinying Lu; Zhen Zeng; Jianhui Qu; Min Lou; Yan Chen; Linjing An; Yongping Yang; M Eric Gershwin
Journal:  Clin Rev Allergy Immunol       Date:  2015-06       Impact factor: 8.667

7.  Embolization of cyanoacrylate glue in systemic circulation in a case of hepatocellular carcinoma: an autopsy report.

Authors:  Kirti Gupta; Rakesh K Vasishta; Usha Dutta; Rakesh K Kochhar; Kartar Singh
Journal:  Diagn Pathol       Date:  2009-12-09       Impact factor: 2.644

8.  Incidence of Hepatocellular Carcinoma in Primary Biliary Cholangitis: A Systematic Review and Meta-Analysis.

Authors:  Yamini Natarajan; Aylin Tansel; Parth Patel; Kingsley Emologu; Richa Shukla; Zeeshan Qureshi; Hashem B El-Serag; Aaron P Thrift; Fasiha Kanwal
Journal:  Dig Dis Sci       Date:  2020-08-02       Impact factor: 3.199

Review 9.  Iron at the Interface of Hepatocellular Carcinoma.

Authors:  Rossana Paganoni; André Lechel; Maja Vujic Spasic
Journal:  Int J Mol Sci       Date:  2021-04-15       Impact factor: 5.923

10.  Nonalcoholic Cirrhosis Increased Risk of Digestive Tract Malignancies: A Population-Based Cohort Study.

Authors:  Li-Min Sun; Ming-Chia Lin; Cheng-Li Lin; Ji-An Liang; Long-Bin Jeng; Chia-Hung Kao; Chiao-Yi Lu
Journal:  Medicine (Baltimore)       Date:  2015-12       Impact factor: 1.817

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.